低甲基化药物和 Venetoclax 治疗造血干细胞移植后复发的急性髓性白血病

Filip Ionescu, Jerel C David, Apoorva Ravichandran, D. Sallman, K. Sweet, R. Komrokji, O. Chan, A. Kuykendall, E. Padron, R. Faramand, N. Bejanyan, F. Khimani, H. Elmariah, J. Pidala, A. Mishra, Lia Perez, T. Nishihori, J. Lancet
{"title":"低甲基化药物和 Venetoclax 治疗造血干细胞移植后复发的急性髓性白血病","authors":"Filip Ionescu, Jerel C David, Apoorva Ravichandran, D. Sallman, K. Sweet, R. Komrokji, O. Chan, A. Kuykendall, E. Padron, R. Faramand, N. Bejanyan, F. Khimani, H. Elmariah, J. Pidala, A. Mishra, Lia Perez, T. Nishihori, J. Lancet","doi":"10.1016/j.clml.2024.02.005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":503375,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"85 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hypomethylating agents and venetoclax for acute myeloid leukemia relapsed after hematopoietic stem cell transplant\",\"authors\":\"Filip Ionescu, Jerel C David, Apoorva Ravichandran, D. Sallman, K. Sweet, R. Komrokji, O. Chan, A. Kuykendall, E. Padron, R. Faramand, N. Bejanyan, F. Khimani, H. Elmariah, J. Pidala, A. Mishra, Lia Perez, T. Nishihori, J. Lancet\",\"doi\":\"10.1016/j.clml.2024.02.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":503375,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"85 17\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.clml.2024.02.005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.clml.2024.02.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Hypomethylating agents and venetoclax for acute myeloid leukemia relapsed after hematopoietic stem cell transplant
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study Hypomethylating agents and venetoclax for acute myeloid leukemia relapsed after hematopoietic stem cell transplant Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1